India Demonstrates Strong Market Potential with Rising Obesity Prevalence Revenue from obesity GLP-1 treatment in India is expanding at a CAGR of 28.4%, supported by increasing obesity rates in metropolitan areas and growing awareness of cardiovascular risk factors
Despite these improvements, persistence declines sharply over longer durations, with only 14% of patients remaining on Wegovy after three years
Researchers should understand this context when sourcing materials and planning protocols
Focus on compound movements (squats, deadlifts, presses, rows, pull-ups) that engage multiple muscle groups simultaneously
The experiments revealed that gastric secretion was stimulated by the consumption of mixed meals, meats and milk, but was inhibited by fatty food and possibly aided by an adaptive immune response (Ivy, Lim, McCarthy
A recurring theme across non-incretin metabolic peptides is that early development efforts were constrained by pleiotropy, cardiovascular effects, or incomplete receptor characterization rather than by lack of metabolic relevance
